市場調査レポート

商品コード

1472992

局所ドラッグデリバリー市場の評価：製品・投与経路・用途・エンドユーザー・流通チャネル・地域別の機会および予測 (2017-2031年)

Topical Drug Delivery Market Assessment, By Product, By Route of Administration, By Application, By End-user, By Distribution Channel, By Region, Opportunities and Forecast, 2017-2031F

出版日: 2024年05月01日 | 発行: Market Xcel - Markets and Data

| ページ情報: 英文 231 Pages | 納期: 3～5営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　詳細はお問い合わせください。

価格

PDF & Excel Printable (Single User License)

USD 4,500 706,095円

レポートPDFを1名の方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能です。印刷は無制限で可能です。Excelのデータがライセンスに含まれています。

PDF & Excel Printable (Corporate License)

USD 5,700 894,387円

レポートPDFを企業の１カ国の拠点のすべての方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能ですが、企業内部での利用に限定されます。ご利用に際しては、あらかじめ出版社の許諾を得る必要があります。詳細はお問合せください。印刷は可能です。Excelのデータがライセンスに含まれています。

PDF & Excel Printable (Custom Research License)

USD 8,200 1,286,662円

レポートPDFを企業の１カ国の拠点のすべての方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能です。印刷は無制限で可能です。Excelのデータがライセンスに含まれています。アナリストアワー100時間が含まれており、レポートのカスタマイズなどにご利用いただけます。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=156.91円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

世界の局所ドラッグデリバリーの市場規模は、2023年の2,512億米ドルから、2024年から2031年の予測期間中は9.03%のCAGRで推移し、2031年には5,016億3,000万米ドルの規模に成長すると予測されています。

R&D活動の活発化、癌、感染症、糖尿病、呼吸器疾患の罹患率の上昇、注射針恐怖症の増加が市場拡大を支えています。

世界の局所ドラッグデリバリー市場の拡大は、不快感を与えず、投与に医療専門家を必要としない便利なドラッグデリバリーソリューションに対する需要の高まりに起因しています。また、さまざまな皮膚疾患の有病率の増加も、市場拡大の要因となっています。火傷の発生件数の増加は、火傷の効果的な管理と治療のための局所薬剤の必要性を高めています。

関節リウマチのようなさまざまな疾患や障害の治療効果を高めるために、マイクロニードルパッチを用いてさまざまな薬剤を投与するためのさまざまな研究活動が進行中です。関節内注射による薬剤の局所投与は痛みを伴うため、低侵襲で炎症部位に抗関節炎薬を持続的に放出できるドラッグデリバリーソリューションが求められています。現在、モルモットモデルにおいて、メトトレキサートの低侵襲かつ局所的なデリバリーのためのマイクロニードルパッチの開発に焦点を当てた研究が行われています。このパッチは、薬剤の徐放性を確保し、従来の皮下注射による治療や未治療のままと比較して、最小限の免疫反応を誘発し、関節のリウマチマーカーや炎症が明らかに減少することが判明しました。

R&D活動の活発化が局所ドラッグデリバリー市場の世界的成長を支える：

さまざまなR&D活動への投資の増加は、予測期間にわたって市場に有利な成長機会を提供すると期待されています。R&D活動が重視されるようになった背景には、局所ドラッグデリバリーシステムが提供するさまざまな利点（使いやすさ、自己投与可能性、痛みのない薬物送達、費用対効果など）に対する意識の高まりがあります。

関節リウマチを経皮ドラッグデリバリーシステムで治療するために、さまざまな研究活動が進行中です。関節リウマチの治療に経皮ドラッグデリバリーシステムを利用することで、さまざまな副作用を回避し、患者のコンプライアンスを高めることができるため、有望な選択肢となっています。生体高分子や低分子薬剤を送達する経皮ドラッグデリバリーシステムは、関節リウマチ治療の効果的な手段となることが期待されています。

火傷の増加：

さまざまな環境的、化学的、電気的要因による火傷の発生件数の増加が、世界の局所ドラッグデリバリー市場の需要を押し上げています。世界保健機関（WHO）の推計によると、毎年約18万人が火傷によって死亡しています。この数の多さが、火傷を効果的に管理・治療するための局所薬剤の必要性を高めています。感染のリスクは、外用抗菌薬の助けを借りて最小限に抑えることができます。これらの薬剤は、合併症や創傷の重症度によって敗血症のリスクがある患者にも使用されます。外用薬は比較的使いやすく、痛みを伴わない投与が可能であることも、火傷創の治療に好まれる大きな要因です。

当レポートでは、世界の局所ドラッグデリバリーの市場を調査し、市場の定義と概要、市場規模の推移・予測、各種区分・地域別の詳細分析、産業構造、市場成長への影響因子の分析、ケーススタディ、競合情勢、主要企業のプロファイルなどをまとめています。

市場規模・予測
製品別
- 固形製剤
- 液体製剤
- 半固形製剤
- 経皮吸収製品
投与経路別
- 眼
- 直腸
- 肌
- 膣
- 鼻腔
- 肺
- 皮膚
- その他
用途別
- 癌
- 感染症
- 糖尿病
- 呼吸器疾患
- 心血管疾患
- その他
エンドユーザー別
- 病院・診療所
- 火傷センター
- 在宅ケア
- 診断センター
- その他
流通チャネル別
- 小売
- 直接入札
地域別
- 北米
- 南米
- 欧州
- アジア太平洋
- 中東・アフリカ
企業別市場シェア（％）、2023年

第5章世界の局所ドラッグデリバリー市場の展望：地域別

北米
欧州
アジア太平洋
南米
中東・アフリカ

第6章市場マッピング

製品別
投与経路別
用途別
エンドユーザー別
流通チャネル別
地域別

第7章マクロ環境と産業構造

需給分析
輸出入分析
バリューチェーン分析
PESTEL分析
ポーターのファイブフォース分析

第8章市場力学

成長促進要因
成長抑制要因 (課題と抑制)

第9章規制の枠組みとイノベーション

特許情勢
規制当局の承認
イノベーション/新興技術

第10章主要企業の情勢

市場リーダー上位5社の競合マトリックス
市場リーダー上位5社の市場収益分析
M&A・ジョイントベンチャー (該当する場合)
SWOT分析（参入5社）
特許分析（該当する場合）

第11章価格分析

第12章ケーススタディ

第13章主要企業の展望

M Company
Johnson & Johnson Private Limited
GlaxoSmithKline PLC
Novartis AG
Bayer AG
Galderma Holding SA
Hisamitsu Pharmaceuticals
Merck & Co., Inc.
MedPharm Group Ltd.
Glenmark Pharmaceuticals Ltd.

第14章戦略的提言

第15章当社について・免責事項

図表

List of Tables

Table 1. Pricing Analysis of Products from Key Players
Table 2. Competition Matrix of Top 5 Market Leaders
Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

Figure 1.Global Topical Drug Delivery Market, By Value, In USD Billion, 2017-2031F
Figure 2.Global Topical Drug Delivery Market, By Volume, In Million Units, 2017-2031F
Figure 3.Global Topical Drug Delivery Market Share (%), By Product, 2017-2031F
Figure 4.Global Topical Drug Delivery Market Share (%), By Route of Administration, 2017-2031F
Figure 5.Global Topical Drug Delivery Market Share (%), By Application, 2017-2031F
Figure 6.Global Topical Drug Delivery Market Share (%), By End-user, 2017-2031F
Figure 7.Global Topical Drug Delivery Market Share (%), By Distribution Channel, 2017-2031F
Figure 8.Global Topical Drug Delivery Market Share (%), By Region, 2017-2031F
Figure 9.North America Topical Drug Delivery Market, By Value, In USD Billion, 2017-2031F
Figure 10.North America Topical Drug Delivery Market, By Volume, In Million Units, 2017-2031F
Figure 11.North America Topical Drug Delivery Market Share (%), By Product, 2017-2031F
Figure 12.North America Topical Drug Delivery Market Share (%), By Route of Administration, 2017-2031F
Figure 13.North America Topical Drug Delivery Market Share (%), By Application, 2017-2031F
Figure 14.North America Topical Drug Delivery Market Share (%), By End-user, 2017-2031F
Figure 15.North America Topical Drug Delivery Market Share (%), By Distribution Channel, 2017-2031F
Figure 16.North America Topical Drug Delivery Market Share (%), By Country, 2017-2031F
Figure 17.United States Topical Drug Delivery Market, By Value, In USD Billion, 2017-2031F
Figure 18.United States Topical Drug Delivery Market, By Volume, In Million Units, 2017-2031F
Figure 19.United States Topical Drug Delivery Market Share (%), By Product, 2017-2031F
Figure 20.United States Topical Drug Delivery Market Share (%), By Route of Administration, 2017-2031F
Figure 21.United States Topical Drug Delivery Market Share (%), By Application, 2017-2031F
Figure 22.United States Topical Drug Delivery Market Share (%), By End-user, 2017-2031F
Figure 23.United States Topical Drug Delivery Market Share (%), By Distribution Channel, 2017-2031F
Figure 24.Canada Topical Drug Delivery Market, By Value, In USD Billion, 2017-2031F
Figure 25.Canada Topical Drug Delivery Market, By Volume, In Million Units, 2017-2031F
Figure 26.Canada Topical Drug Delivery Market Share (%), By Product, 2017-2031F
Figure 27.Canada Topical Drug Delivery Market Share (%), By Route of Administration, 2017-2031F
Figure 28.Canada Topical Drug Delivery Market Share (%), By Application, 2017-2031F
Figure 29.Canada Topical Drug Delivery Market Share (%), By End-user, 2017-2031F
Figure 30.Canada Topical Drug Delivery Market Share (%), By Distribution Channel, 2017-2031F
Figure 31.Mexico Topical Drug Delivery Market, By Value, In USD Billion, 2017-2031F
Figure 32.Mexico Topical Drug Delivery Market, By Volume, In Million Units, 2017-2031F
Figure 33.Mexico Topical Drug Delivery Market Share (%), By Product, 2017-2031F
Figure 34.Mexico Topical Drug Delivery Market Share (%), By Route of Administration, 2017-2031F
Figure 35.Mexico Topical Drug Delivery Market Share (%), By Application, 2017-2031F
Figure 36.Mexico Topical Drug Delivery Market Share (%), By End-user, 2017-2031F
Figure 37.Mexico Topical Drug Delivery Market Share (%), By Distribution Channel, 2017-2031F
Figure 38.Europe Topical Drug Delivery Market, By Value, In USD Billion, 2017-2031F
Figure 39.Europe Topical Drug Delivery Market, By Volume, In Million Units, 2017-2031F
Figure 40.Europe Topical Drug Delivery Market Share (%), By Product, 2017-2031F
Figure 41.Europe Topical Drug Delivery Market Share (%), By Route of Administration, 2017-2031F
Figure 42.Europe Topical Drug Delivery Market Share (%), By Application, 2017-2031F
Figure 43.Europe Topical Drug Delivery Market Share (%), By End-user, 2017-2031F
Figure 44.Europe Topical Drug Delivery Market Share (%), By Distribution Channel, 2017-2031F
Figure 45.Europe Topical Drug Delivery Market Share (%), By Country, 2017-2031F
Figure 46.Germany Topical Drug Delivery Market, By Value, In USD Billion, 2017-2031F
Figure 47.Germany Topical Drug Delivery Market, By Volume, In Million Units, 2017-2031F
Figure 48.Germany Topical Drug Delivery Market Share (%), By Product, 2017-2031F
Figure 49.Germany Topical Drug Delivery Market Share (%), By Route of Administration, 2017-2031F
Figure 50.Germany Topical Drug Delivery Market Share (%), By Application, 2017-2031F
Figure 51.Germany Topical Drug Delivery Market Share (%), By End-user, 2017-2031F
Figure 52.Germany Topical Drug Delivery Market Share (%), By Distribution Channel, 2017-2031F
Figure 53.France Topical Drug Delivery Market, By Value, In USD Billion, 2017-2031F
Figure 54.France Topical Drug Delivery Market, By Volume, In Million Units, 2017-2031F
Figure 55.France Topical Drug Delivery Market Share (%), By Product, 2017-2031F
Figure 56.France Topical Drug Delivery Market Share (%), By Route of Administration, 2017-2031F
Figure 57.France Topical Drug Delivery Market Share (%), By Application, 2017-2031F
Figure 58.France Topical Drug Delivery Market Share (%), By End-user, 2017-2031F
Figure 59.France Topical Drug Delivery Market Share (%), By Distribution Channel, 2017-2031F
Figure 60.Italy Topical Drug Delivery Market, By Value, In USD Billion, 2017-2031F
Figure 61.Italy Topical Drug Delivery Market, By Volume, In Million Units, 2017-2031F
Figure 62.Italy Topical Drug Delivery Market Share (%), By Product, 2017-2031F
Figure 63.Italy Topical Drug Delivery Market Share (%), By Route of Administration, 2017-2031F
Figure 64.Italy Topical Drug Delivery Market Share (%), By Application, 2017-2031F
Figure 65.Italy Topical Drug Delivery Market Share (%), By End-user, 2017-2031F
Figure 66.Italy Topical Drug Delivery Market Share (%), By Distribution Channel, 2017-2031F
Figure 67.United Kingdom Topical Drug Delivery Market, By Value, In USD Billion, 2017-2031F
Figure 68.United Kingdom Topical Drug Delivery Market, By Volume, In Million Units, 2017-2031F
Figure 69.United Kingdom Topical Drug Delivery Market Share (%), By Product, 2017-2031F
Figure 70.United Kingdom Topical Drug Delivery Market Share (%), By Route of Administration, 2017-2031F
Figure 71.United Kingdom Topical Drug Delivery Market Share (%), By Application, 2017-2031F
Figure 72.United Kingdom Topical Drug Delivery Market Share (%), By End-user, 2017-2031F
Figure 73.United Kingdom Topical Drug Delivery Market Share (%), By Distribution Channel, 2017-2031F
Figure 74.Russia Topical Drug Delivery Market, By Value, In USD Billion, 2017-2031F
Figure 75.Russia Topical Drug Delivery Market, By Volume, In Million Units, 2017-2031F
Figure 76.Russia Topical Drug Delivery Market Share (%), By Product, 2017-2031F
Figure 77.Russia Topical Drug Delivery Market Share (%), By Route of Administration, 2017-2031F
Figure 78.Russia Topical Drug Delivery Market Share (%), By Application, 2017-2031F
Figure 79.Russia Topical Drug Delivery Market Share (%), By End-user, 2017-2031F
Figure 80.Russia Topical Drug Delivery Market Share (%), By Distribution Channel, 2017-2031F
Figure 81.Netherlands Topical Drug Delivery Market, By Value, In USD Billion, 2017-2031F
Figure 82.Netherlands Topical Drug Delivery Market, By Volume, In Million Units, 2017-2031F
Figure 83.Netherlands Topical Drug Delivery Market Share (%), By Product, 2017-2031F
Figure 84.Netherlands Topical Drug Delivery Market Share (%), By Route of Administration, 2017-2031F
Figure 85.Netherlands Topical Drug Delivery Market Share (%), By Application, 2017-2031F
Figure 86.Netherlands Topical Drug Delivery Market Share (%), By End-user, 2017-2031F
Figure 87.Netherlands Topical Drug Delivery Market Share (%), By Distribution Channel, 2017-2031F
Figure 88.Spain Topical Drug Delivery Market, By Value, In USD Billion, 2017-2031F
Figure 89.Spain Topical Drug Delivery Market, By Volume, In Million Units, 2017-2031F
Figure 90.Spain Topical Drug Delivery Market Share (%), By Product, 2017-2031F
Figure 91.Spain Topical Drug Delivery Market Share (%), By Route of Administration, 2017-2031F
Figure 92.Spain Topical Drug Delivery Market Share (%), By Application, 2017-2031F
Figure 93.Spain Topical Drug Delivery Market Share (%), By End-user, 2017-2031F
Figure 94.Spain Topical Drug Delivery Market Share (%), By Distribution Channel, 2017-2031F
Figure 95.Turkey Topical Drug Delivery Market, By Value, In USD Billion, 2017-2031F
Figure 96.Turkey Topical Drug Delivery Market, By Volume, In Million Units, 2017-2031F
Figure 97.Turkey Topical Drug Delivery Market Share (%), By Product, 2017-2031F
Figure 98.Turkey Topical Drug Delivery Market Share (%), By Route of Administration, 2017-2031F
Figure 99.Turkey Topical Drug Delivery Market Share (%), By Application, 2017-2031F
Figure 100.Turkey Topical Drug Delivery Market Share (%), By End-user, 2017-2031F
Figure 101.Turkey Topical Drug Delivery Market Share (%), By Distribution Channel, 2017-2031F
Figure 102.Poland Topical Drug Delivery Market, By Value, In USD Billion, 2017-2031F
Figure 103.Poland Topical Drug Delivery Market, By Volume, In Million Units, 2017-2031F
Figure 104.Poland Topical Drug Delivery Market Share (%), By Product, 2017-2031F
Figure 105.Poland Topical Drug Delivery Market Share (%), By Route of Administration, 2017-2031F
Figure 106.Poland Topical Drug Delivery Market Share (%), By Application, 2017-2031F
Figure 107.Poland Topical Drug Delivery Market Share (%), By End-user, 2017-2031F
Figure 108.Poland Topical Drug Delivery Market Share (%), By Distribution Channel, 2017-2031F
Figure 109.South America Topical Drug Delivery Market, By Value, In USD Billion, 2017-2031F
Figure 110.South America Topical Drug Delivery Market, By Volume, In Million Units, 2017-2031F
Figure 111.South America Topical Drug Delivery Market Share (%), By Product, 2017-2031F
Figure 112.South America Topical Drug Delivery Market Share (%), By Route of Administration, 2017-2031F
Figure 113.South America Topical Drug Delivery Market Share (%), By Application, 2017-2031F
Figure 114.South America Topical Drug Delivery Market Share (%), By End-user, 2017-2031F
Figure 115.South America Topical Drug Delivery Market Share (%), By Distribution Channel, 2017-2031F
Figure 116.South America Topical Drug Delivery Market Share (%), By Country, 2017-2031F
Figure 117.Brazil Topical Drug Delivery Market, By Value, In USD Billion, 2017-2031F
Figure 118.Brazil Topical Drug Delivery Market, By Volume, In Million Units, 2017-2031F
Figure 119.Brazil Topical Drug Delivery Market Share (%), By Product, 2017-2031F
Figure 120.Brazil Topical Drug Delivery Market Share (%), By Route of Administration, 2017-2031F
Figure 121.Brazil Topical Drug Delivery Market Share (%), By Application, 2017-2031F
Figure 122.Brazil Topical Drug Delivery Market Share (%), By End-user, 2017-2031F
Figure 123.Brazil Topical Drug Delivery Market Share (%), By Distribution Channel, 2017-2031F
Figure 124.Argentina Topical Drug Delivery Market, By Value, In USD Billion, 2017-2031F
Figure 125.Argentina Topical Drug Delivery Market, By Volume, In Million Units, 2017-2031F
Figure 126.Argentina Topical Drug Delivery Market Share (%), By Product, 2017-2031F
Figure 127.Argentina Topical Drug Delivery Market Share (%), By Route of Administration, 2017-2031F
Figure 128.Argentina Topical Drug Delivery Market Share (%), By Application, 2017-2031F
Figure 129.Argentina Topical Drug Delivery Market Share (%), By End-user, 2017-2031F
Figure 130.Argentina Topical Drug Delivery Market Share (%), By Distribution Channel, 2017-2031F
Figure 131.Asia-Pacific Topical Drug Delivery Market, By Value, In USD Billion, 2017-2031F
Figure 132.Asia-Pacific Topical Drug Delivery Market, By Volume, In Million Units, 2017-2031F
Figure 133.Asia-Pacific Topical Drug Delivery Market Share (%), By Product, 2017-2031F
Figure 134.Asia-Pacific Topical Drug Delivery Market Share (%), By Route of Administration, 2017-2031F
Figure 135.Asia-Pacific Topical Drug Delivery Market Share (%), By Application, 2017-2031F
Figure 136.Asia-Pacific Topical Drug Delivery Market Share (%), By End-user, 2017-2031F
Figure 137.Asia- Pacific Topical Drug Delivery Market Share (%), By Distribution Channel, 2017-2031F
Figure 138.Asia-Pacific Topical Drug Delivery Market Share (%), By Country, 2017-2031F
Figure 139.India Topical Drug Delivery Market, By Value, In USD Billion, 2017-2031F
Figure 140.India Topical Drug Delivery Market, By Volume, In Million Units, 2017-2031F
Figure 141.India Topical Drug Delivery Market Share (%), By Product, 2017-2031F
Figure 142.India Topical Drug Delivery Market Share (%), By Route of Administration, 2017-2031F
Figure 143.India Topical Drug Delivery Market Share (%), By Application, 2017-2031F
Figure 144.India Topical Drug Delivery Market Share (%), By End-user, 2017-2031F
Figure 145.India Topical Drug Delivery Market Share (%), By Distribution Channel, 2017-2031F
Figure 146.China Topical Drug Delivery Market, By Value, In USD Billion, 2017-2031F
Figure 147.China Topical Drug Delivery Market, By Volume, In Million Units, 2017-2031F
Figure 148.China Topical Drug Delivery Market Share (%), By Product, 2017-2031F
Figure 149.China Topical Drug Delivery Market Share (%), By Route of Administration, 2017-2031F
Figure 150.China Topical Drug Delivery Market Share (%), By Application, 2017-2031F
Figure 151.China Topical Drug Delivery Market Share (%), By End-user, 2017-2031F
Figure 152.China Topical Drug Delivery Market Share (%), By Distribution Channel, 2017-2031F
Figure 153.Japan Topical Drug Delivery Market, By Value, In USD Billion, 2017-2031F
Figure 154.Japan Topical Drug Delivery Market, By Volume, In Million Units, 2017-2031F
Figure 155.Japan Topical Drug Delivery Market Share (%), By Product, 2017-2031F
Figure 156.Japan Topical Drug Delivery Market Share (%), By Route of Administration, 2017-2031F
Figure 157.Japan Topical Drug Delivery Market Share (%), By Application, 2017-2031F
Figure 158.Japan Topical Drug Delivery Market Share (%), By End-user, 2017-2031F
Figure 159.Japan Topical Drug Delivery Market Share (%), By Distribution Channel, 2017-2031F
Figure 160.Australia Topical Drug Delivery Market, By Value, In USD Billion, 2017-2031F
Figure 161.Australia Topical Drug Delivery Market, By Volume, In Million Units, 2017-2031F
Figure 162.Australia Topical Drug Delivery Market Share (%), By Product, 2017-2031F
Figure 163.Australia Topical Drug Delivery Market Share (%), By Route of Administration, 2017-2031F
Figure 164.Australia Topical Drug Delivery Market Share (%), By Application, 2017-2031F
Figure 165.Australia Topical Drug Delivery Market Share (%), By End-user, 2017-2031F
Figure 166.Australia Topical Drug Delivery Market Share (%), By Distribution Channel, 2017-2031F
Figure 167.Vietnam Topical Drug Delivery Market, By Value, In USD Billion, 2017-2031F
Figure 168.Vietnam Topical Drug Delivery Market, By Volume, In Million Units, 2017-2031F
Figure 169.Vietnam Topical Drug Delivery Market Share (%), By Product, 2017-2031F
Figure 170.Vietnam Topical Drug Delivery Market Share (%), By Route of Administration, 2017-2031F
Figure 171.Vietnam Topical Drug Delivery Market Share (%), By Application, 2017-2031F
Figure 172.Vietnam Topical Drug Delivery Market Share (%), By End-user, 2017-2031F
Figure 173.Vietnam Topical Drug Delivery Market Share (%), By Distribution Channel, 2017-2031F
Figure 174.South Korea Topical Drug Delivery Market, By Value, In USD Billion, 2017-2031F
Figure 175.South Korea Topical Drug Delivery Market, By Volume, In Million Units, 2017-2031F
Figure 176.South Korea Topical Drug Delivery Market Share (%), By Product, 2017-2031F
Figure 177.South Korea Topical Drug Delivery Market Share (%), By Route of Administration, 2017-2031F
Figure 178.South Korea Topical Drug Delivery Market Share (%), By Application, 2017-2031F
Figure 179.South Korea Topical Drug Delivery Market Share (%), By End-user, 2017-2031F
Figure 180.South Korea Topical Drug Delivery Market Share (%), By Distribution Channel, 2017-2031F
Figure 181.Indonesia Topical Drug Delivery Market, By Value, In USD Billion, 2017-2031F
Figure 182.Indonesia Topical Drug Delivery Market, By Volume, In Million Units, 2017-2031F
Figure 183.Indonesia Topical Drug Delivery Market Share (%), By Product, 2017-2031F
Figure 184.Indonesia Topical Drug Delivery Market Share (%), By Route of Administration, 2017-2031F
Figure 185.Indonesia Topical Drug Delivery Market Share (%), By Application, 2017-2031F
Figure 186.Indonesia Topical Drug Delivery Market Share (%), By End-user, 2017-2031F
Figure 187.Indonesia Topical Drug Delivery Market Share (%), By Distribution Channel, 2017-2031F
Figure 188.Philippines Topical Drug Delivery Market, By Value, In USD Billion, 2017-2031F
Figure 189.Philippines Topical Drug Delivery Market, By Volume, In Million Units, 2017-2031F
Figure 190.Philippines Topical Drug Delivery Market Share (%), By Product, 2017-2031F
Figure 191.Philippines Topical Drug Delivery Market Share (%), By Route of Administration, 2017-2031F
Figure 192.Philippines Topical Drug Delivery Market Share (%), By Application, 2017-2031F
Figure 193.Philippines Topical Drug Delivery Market Share (%), By End-user, 2017-2031F
Figure 194.Philippines Topical Drug Delivery Market Share (%), By Distribution Channel, 2017-2031F
Figure 195.Middle East & Africa Topical Drug Delivery Market, By Value, In USD Billion, 2017-2031F
Figure 196.Middle East & Africa Topical Drug Delivery Market, By Volume, In Million Units, 2017-2031F
Figure 197.Middle East & Africa Topical Drug Delivery Market Share (%), By Product, 2017-2031F
Figure 198.Middle East & Africa Topical Drug Delivery Market Share (%), By Route of Administration, 2017-2031F
Figure 199.Middle East & Africa Topical Drug Delivery Market Share (%), By Application, 2017-2031F
Figure 200.Middle East & Africa Topical Drug Delivery Market Share (%), By End-user, 2017-2031F
Figure 201.Middle East & Africa Topical Drug Delivery Market Share (%), By Distribution Channel, 2017-2031F
Figure 202.Middle East & Africa Topical Drug Delivery Market Share (%), By Country, 2017-2031F
Figure 203.Saudi Arabia Topical Drug Delivery Market, By Value, In USD Billion, 2017-2031F
Figure 204.Saudi Arabia Topical Drug Delivery Market, By Volume, In Million Units, 2017-2031F
Figure 205.Saudi Arabia Topical Drug Delivery Market Share (%), By Product, 2017-2031F
Figure 206.Saudi Arabia Topical Drug Delivery Market Share (%), By Route of Administration, 2017-2031F
Figure 207.Saudi Arabia Topical Drug Delivery Market Share (%), By Application, 2017-2031F
Figure 208.Saudi Arabia Topical Drug Delivery Market Share (%), By End-user, 2017-2031F
Figure 209.Saudi Arabia Topical Drug Delivery Market Share (%), By Distribution Channel, 2017-2031F
Figure 210.UAE Topical Drug Delivery Market, By Value, In USD Billion, 2017-2031F
Figure 211.UAE Topical Drug Delivery Market, By Volume, In Million Units, 2017-2031F
Figure 212.UAE Topical Drug Delivery Market Share (%), By Product, 2017-2031F
Figure 213.UAE Topical Drug Delivery Market Share (%), By Route of Administration, 2017-2031F
Figure 214.UAE Topical Drug Delivery Market Share (%), By Application, 2017-2031F
Figure 215.UAE Topical Drug Delivery Market Share (%), By End-user, 2017-2031F
Figure 216.UAE Topical Drug Delivery Market Share (%), By Distribution Channel, 2017-2031F
Figure 217.South Africa Topical Drug Delivery Market, By Value, In USD Billion, 2017-2031F
Figure 218.South Africa Topical Drug Delivery Market, By Volume, In Million Units, 2017-2031F
Figure 219.South Africa Topical Drug Delivery Market Share (%), By Product, 2017-2031F
Figure 220.South Africa Topical Drug Delivery Market Share (%), By Route of Administration, 2017-2031F
Figure 221.South Africa Topical Drug Delivery Market Share (%), By Application, 2017-2031F
Figure 222.South Africa Topical Drug Delivery Market Share (%), By End-user, 2017-2031F
Figure 223.South Africa Topical Drug Delivery Market Share (%), By Distribution Channel, 2017-2031F
Figure 224.By Product Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 225.By Route of Administration Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 226.By Application Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 227.By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 228.By Distribution Channel Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 229.By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023

Product Code: MX11266

Global topical drug delivery market is projected to witness a CAGR of 9.03% during the forecast period 2024-2031F, growing from USD 251.2 billion in 2023 to USD 501.63 billion in 2031F. Increasing research and development activities, rising incidences of cancer, infectious diseases, diabetes, respiratory diseases, and growing needle phobia support the market expansion.

The increase in global topical drug delivery market size can be attributed to the rising demand for convenient drug delivery solutions that do not cause discomfort and require a medical professional for administration. The growing prevalence of different skin diseases can also be attributed to the market expansion. The increasing incidences of burn injuries are bolstering the requirement for topical drugs for the effective management and treatment of burns.

Various research activities are underway to deliver various drugs with the help of microneedle patches to ensure improved therapeutic efficacy for treating different diseases and disorders, such as rheumatoid arthritis. Due to the painful nature of the localized administration of the drugs via an intra-articular injection, drug delivery solutions that can ensure the sustained release of anti-arthritic drugs at the inflammation site in a minimally invasive manner are required. Research is being conducted that focuses on developing microneedle patches for minimally invasive and localized delivery of methotrexate in a guinea pig model. The patch was found to ensure the sustained release of the drug and elicit a minimal immune response and a distinct reduction in rheumatoid markers and inflammation at the joints compared to those treated through conventional hypodermic injections and remained untreated.

Rising Research and Development Activities Support the Global Topical Drug Delivery Market Growth

Rising investments in different research and development activities are expected to offer lucrative growth opportunities to the market over the forecast period. The increasing emphasis on research and development activities can be attributed to the rising awareness about the various benefits offered by topical drug delivery systems, such as ease of use, ability to be self-administered, painless delivery of medication, and cost-effectiveness.

Different research activities are underway to treat rheumatoid arthritis with transdermal drug delivery systems. Utilizing transdermal drug delivery systems for treating rheumatoid arthritis will help avoid various adverse effects, suboptimal bioavailability, and nonnegligible first-pass effects and enhance patient compliance, making them a promising option. The potential offered by transdermal drug delivery systems for delivering biomacromolecules and small-molecule drugs is expected to make them an effective means of treating rheumatoid arthritis.

Increasing Incidences of Burn Injuries

The increasing incidences of burn-related injuries due to various environmental, chemical, and electrical factors are boosting the global topical drug delivery market demand. As per the estimates of the World Health Organization (WHO), approximately 180,000 deaths are caused by burns every year. The high number of cases propels the need for topical drugs to manage and treat burns effectively. With the help of topical antimicrobial agents, the threat of infections is minimized. These drugs are also used by patients who are at risk from sepsis due to the associated comorbid factors or because of the severity of the wound. The relatively easy-to-use nature of topical drugs coupled with their painless administration are other significant factors because of which they are preferred for treating burn wounds.

North America is Expected to Witness Significant Market Expansion

Growing research and development activities, a well-established healthcare sector, and novel product launches by leading market players are supporting the expansion of the market. The increasing prevalence of various skin diseases in the region is another major factor bolstering the growth of the North American topical drug delivery market. According to the estimates of the American Cancer Society, approximately 100,640 new cases of melanoma will be diagnosed in the United States in 2024. About 41,470 cases are expected to be diagnosed in women and 59,170 in men.

Increasing spending on different research and development activities by various research institutions is another major factor bolstering the market growth in the region. For instance, the Medical University of South Carolina is conducting an interventional study to analyze the effects of the topical application of Aldara on patients with oral cancer. Aldara activates immune cells to eliminate and attack cancer cells and activates toll-like receptors in oral cancer cells, resulting in the self-destruction of tumor cells. The drug is currently approved by the Food and Drug Administration (FDA) for treating melanoma and skin cancer. The study is expected to conclude in March 2024.

Semi-solid Formulations Anticipated to Account for a Significant Global Topical Drug Delivery Market Share

The ease of use associated with semi-solid formulations such as creams, lotions, ointments, gels, and pastes is one of the major factors boosting segment growth. The stability offered by these products in atmospheric conditions as opposed to their solid and liquid counterparts, coupled with their high absorption properties, are propelling the requirement of semi-solid formulations. Increasing the provision of clearance by different regulatory bodies, such as the Food and Drug Administration (FDA), for various topical creams is another major factor supporting segment expansion. For instance, in 2023, Zydus Lifesciences Limited received approval from the Food and Drug Administration (FDA) to market and manufacture Metronidazole Topical Cream, 0.75 percent. Metronidazole is used to treat rosacea and is expected to aid in reducing swelling, redness, and pimples.

Home Care Settings Boost Global Topical Drug Delivery Market Demand

The growing popularity of home care settings can be attributed to the increasing awareness of the various associated advantages. These advantages include improved treatment outcomes and medical adherence, convenient nature compared to inpatient care, and different benefits for long-term therapy. The home healthcare industry in the United States is anticipated to add over 1 million new jobs between 2019 and 2029. The segment's expansion can also be attributed to the growth of the geriatric populace. According to the World Health Organization (WHO) estimate, between 2015 and 2050, the population over 60 will increase from 12% to 22%. Due to the hassle associated with outpatient treatment and hospitalization, various patients also prefer receiving treatment in home care settings for chronic or long-lasting conditions.

Future Market Scenario (2024-2031F)

According to the global topical drug delivery market analysis, the development of noninvasive and uncomplicated therapeutic strategies and target-oriented topical therapies is necessary in the future. Recent technological advancements in the delivery of drugs via the topical route have been transformed because of a deeper understanding of the permeation pathways through the skin and the molecular-level structure of the stratum corneum.

Various leading public research universities are conducting different studies. For instance, the University of Alabama at Birmingham is conducting a randomized, placebo-controlled, single-institution, double-blind phase IIB trial of topical DFMO and topical diclofenac in subjects who have a history of skin cancer. The participants of the study are 18 or older and have extensive actinic damage and a history of non-melanoma skin cancer. The participants of the study will be randomized to topical DFMO and topical diclofenac and placebo for the topical DFMO and placebo for the topical diclofenac once daily. The study is expected to conclude in December 2024.

Key Players Landscape and Outlook

Key participants in the topical drug delivery market support the growth by increasing research and development activities and raising investments to support such activities.

In 2023, Satio, a leading provider of technology solutions for therapeutics and diagnostics, was awarded a USD 3.5 million Small Business Innovation Research (SBIR) contract by the National Institute of Health's (NIH) Advanced Research Projects Agency for Health (ARPA-H). The contract is expected to support the development of SatioRx, an inexpensive and compact drug delivery device equipped with disposable microneedle components to ensure precise delivery of drugs. Under the contract, the company expects to leverage design features from its other patch-based devices. They also plan on utilizing feasibility data from their manually operated transdermal delivery devices. With these combination, Satio plans to develop a remotely controllable next-generation device.

1.Research Methodology

2.Project Scope & Definitions

3.Executive Summary

4.Global Topical Drug Delivery Market Outlook, 2017-2031F

4.1.Market Size & Forecast
- 4.1.1.By Value
- 4.1.2.By Volume
4.2.By Product
- 4.2.1.Solid Formulations
  - 4.2.1.1.Powders
  - 4.2.1.2.Suppositories
- 4.2.2.Liquid Formulations
  - 4.2.2.1.Suspensions
  - 4.2.2.2.Solutions
- 4.2.3.Semi-solid formulations
  - 4.2.3.1.Creams
  - 4.2.3.2.Ointments
  - 4.2.3.3.Lotions
  - 4.2.3.4.Gel
  - 4.2.3.5.Pastes
- 4.2.4.Transdermal Products
  - 4.2.4.1.Transdermal Patches
  - 4.2.4.2.Transdermal Semi-solids
4.3.By Route of Administration
- 4.3.1.Ophthalmic
- 4.3.2.Rectal
- 4.3.3.Skin
- 4.3.4.Vaginal
- 4.3.5.Nasal
- 4.3.6.Pulmonary
- 4.3.7.Dermal
- 4.3.8.Others
4.4.By Application
- 4.4.1.Cancer
- 4.4.2.Infectious Diseases
- 4.4.3.Diabetes
- 4.4.4.Respiratory Diseases
- 4.4.5.Cardiovascular Diseases
- 4.4.6.Others
4.5.By End-user
- 4.5.1.Hospitals and Clinics
- 4.5.2.Burn Centers
- 4.5.3.Home Care Settings
- 4.5.4.Diagnostic Centers
- 4.5.5.Others
4.6.By Distribution Channel
- 4.6.1.Retail
- 4.6.2.Direct Tender
4.7.By Region
- 4.7.1.North America
- 4.7.2.South America
- 4.7.3.Europe
- 4.7.4.Asia-Pacific
- 4.7.5.Middle East & Africa
4.8.By Company Market Share (%), 2023

5.Global Topical Drug Delivery Market Outlook, By Region, 2017-2031F

5.1.North America*
- 5.1.1.Market Size & Forecast
  - 5.1.1.1.By Value
  - 5.1.1.2.By Volume
- 5.1.2.By Product
  - 5.1.2.1.Solid Formulations
    - 5.1.2.1.1.Powders
    - 5.1.2.1.2.Suppositories
  - 5.1.2.2.Liquid Formulations
    - 5.1.2.2.1.Suspensions
    - 5.1.2.2.2.Solutions
  - 5.1.2.3.Semi-solid formulations
    - 5.1.2.3.1.Creams
    - 5.1.2.3.2.Ointments
    - 5.1.2.3.3.Lotions
    - 5.1.2.3.4.Gel
    - 5.1.2.3.5.Pastes
  - 5.1.2.4.Transdermal Products
    - 5.1.2.4.1.Transdermal Patches
    - 5.1.2.4.2.Transdermal Semi-solids
- 5.1.3.By Route of Administration
  - 5.1.3.1.Ophthalmic
  - 5.1.3.2.Rectal
  - 5.1.3.3.Skin
  - 5.1.3.4.Vaginal
  - 5.1.3.5.Nasal
  - 5.1.3.6.Pulmonary
  - 5.1.3.7.Dermal
  - 5.1.3.8.Others
- 5.1.4.By Application
  - 5.1.4.1.Cancer
  - 5.1.4.2.Infectious Diseases
  - 5.1.4.3.Diabetes
  - 5.1.4.4.Respiratory Diseases
  - 5.1.4.5.Cardiovascular Diseases
  - 5.1.4.6.Others
- 5.1.5.By End-user
  - 5.1.5.1.Hospitals and Clinics
  - 5.1.5.2.Burn Centers
  - 5.1.5.3.Home Care Settings
  - 5.1.5.4.Diagnostic Centers
  - 5.1.5.5.Others
- 5.1.6.By Distribution Channel
  - 5.1.6.1.Retail
  - 5.1.6.2.Direct Tender
- 5.1.7.United States*
  - 5.1.7.1.Market Size & Forecast
    - 5.1.7.1.1.By Value
    - 5.1.7.1.2.By Volume
  - 5.1.7.2.By Product
    - 5.1.7.2.1.Solid Formulations
      - 5.1.7.2.1.1.Powders
      - 5.1.7.2.1.2.Suppositories
    - 5.1.7.2.2.Liquid Formulations
      - 5.1.7.2.2.1.Suspensions
      - 5.1.7.2.2.2.Solutions
    - 5.1.7.2.3.Semi-solid formulations
      - 5.1.7.2.3.1.Creams
      - 5.1.7.2.3.2.Ointments
      - 5.1.7.2.3.3.Lotions
      - 5.1.7.2.3.4.Gel
      - 5.1.7.2.3.5.Pastes
    - 5.1.7.2.4.Transdermal Products
      - 5.1.7.2.4.1.Transdermal Patches
      - 5.1.7.2.4.2.Transdermal Semi-solids
  - 5.1.7.3.By Route of Administration
    - 5.1.7.3.1.Ophthalmic
    - 5.1.7.3.2.Rectal
    - 5.1.7.3.3.Skin
    - 5.1.7.3.4.Vaginal
    - 5.1.7.3.5.Nasal
    - 5.1.7.3.6.Pulmonary
    - 5.1.7.3.7.Dermal
    - 5.1.7.3.8.Others
  - 5.1.7.4.By Application
    - 5.1.7.4.1.Cancer
    - 5.1.7.4.2.Infectious Diseases
    - 5.1.7.4.3.Diabetes
    - 5.1.7.4.4.Respiratory Diseases
    - 5.1.7.4.5.Cardiovascular Diseases
    - 5.1.7.4.6.Others
  - 5.1.7.5.By End-user
    - 5.1.7.5.1.Hospitals and Clinics
    - 5.1.7.5.2.Burn Centers
    - 5.1.7.5.3.Home Care Settings
    - 5.1.7.5.4.Diagnostic Centers
    - 5.1.7.5.5.Others
  - 5.1.7.6.By Distribution Channel
    - 5.1.7.6.1.Retail
    - 5.1.7.6.2.Direct Tender
- 5.1.8.Canada
- 5.1.9.Mexico

All segments will be provided for all regions and countries covered

5.2.Europe
- 5.2.1.Germany
- 5.2.2.France
- 5.2.3.Italy
- 5.2.4.United Kingdom
- 5.2.5.Russia
- 5.2.6.Netherlands
- 5.2.7.Spain
- 5.2.8.Turkey
- 5.2.9.Poland
5.3.Asia-Pacific
- 5.3.1.India
- 5.3.2.China
- 5.3.3.Japan
- 5.3.4.Australia
- 5.3.5.Vietnam
- 5.3.6.South Korea
- 5.3.7.Indonesia
- 5.3.8.Philippines
5.4.South America
- 5.4.1.Brazil
- 5.4.2.Argentina
5.5.Middle East & Africa
- 5.5.1.Saudi Arabia
- 5.5.2.UAE
- 5.5.3.South Africa

6.Market Mapping, 2023

6.1.By Product
6.2.By Route of Administration
6.3.By Application
6.4.By End-user
6.5.By Distribution Channel
6.6.By Region

7.Macro Environment and Industry Structure

7.1.Supply Demand Analysis
7.2.Import Export Analysis
7.3.Value Chain Analysis
7.4.PESTEL Analysis
- 7.4.1.Political Factors
- 7.4.2.Economic System
- 7.4.3.Social Implications
- 7.4.4.Technological Advancements
- 7.4.5.Environmental Impacts
- 7.4.6.Legal Compliances and Regulatory Policies (Statutory Bodies Included)
7.5.Porter's Five Forces Analysis
- 7.5.1.Supplier Power
- 7.5.2.Buyer Power
- 7.5.3.Substitution Threat
- 7.5.4.Threat from New Entrant
- 7.5.5.Competitive Rivalry

8.Market Dynamics

8.1.Growth Drivers
8.2.Growth Inhibitors (Challenges and Restraints)

9.Regulatory Framework and Innovation

9.1.Patent Landscape
9.2.Regulatory Approvals
9.3.Innovations/Emerging Technologies

10.Key Players Landscape

10.1.Competition Matrix of Top Five Market Leaders
10.2.Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
10.3.Mergers and Acquisitions/Joint Ventures (If Applicable)
10.4.SWOT Analysis (For Five Market Players)
10.5.Patent Analysis (If Applicable)

11.Pricing Analysis

12.Case Studies

13.Key Players Outlook

13.1.3M Company
- 13.1.1.Company Details
- 13.1.2.Key Management Personnel
- 13.1.3.Products & Services
- 13.1.4.Financials (As reported)
- 13.1.5.Key Market Focus & Geographical Presence
- 13.1.6.Recent Developments
13.2.Johnson & Johnson Private Limited
13.3.GlaxoSmithKline PLC
13.4.Novartis AG
13.5.Bayer AG
13.6.Galderma Holding SA
13.7.Hisamitsu Pharmaceuticals
13.8.Merck & Co., Inc.
13.9.MedPharm Group Ltd.
13.10.Glenmark Pharmaceuticals Ltd.

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

局所ドラッグデリバリー市場の評価：製品・投与経路・用途・エンドユーザー・流通チャネル・地域別の機会および予測 (2017-2031年)

Topical Drug Delivery Market Assessment, By Product, By Route of Administration, By Application, By End-user, By Distribution Channel, By Region, Opportunities and Forecast, 2017-2031F

目次

第1章調査手法

第2章プロジェクトの範囲と定義

第3章エグゼクティブサマリー

第4章世界の局所ドラッグデリバリー市場の展望

第5章世界の局所ドラッグデリバリー市場の展望：地域別

第6章市場マッピング

第7章マクロ環境と産業構造

第8章市場力学

第9章規制の枠組みとイノベーション

第10章主要企業の情勢

第11章価格分析

第12章ケーススタディ

第13章主要企業の展望

第14章戦略的提言

第15章当社について・免責事項

List of Tables

List of Figures

Table of Contents

1.Research Methodology

2.Project Scope & Definitions

3.Executive Summary

4.Global Topical Drug Delivery Market Outlook, 2017-2031F

5.Global Topical Drug Delivery Market Outlook, By Region, 2017-2031F

6.Market Mapping, 2023

7.Macro Environment and Industry Structure

8.Market Dynamics

9.Regulatory Framework and Innovation

10.Key Players Landscape

11.Pricing Analysis

12.Case Studies

13.Key Players Outlook

14.Strategic Recommendations

15.About Us & Disclaimer

局所ドラッグデリバリー市場の評価：製品・投与経路・用途・エンドユーザー・流通チャネル・地域別の機会および予測 (2017-2031年)

Topical Drug Delivery Market Assessment, By Product, By Route of Administration, By Application, By End-user, By Distribution Channel, By Region, Opportunities and Forecast, 2017-2031F

目次

第1章 調査手法

第2章 プロジェクトの範囲と定義

第3章 エグゼクティブサマリー

第4章 世界の局所ドラッグデリバリー市場の展望

第5章 世界の局所ドラッグデリバリー市場の展望：地域別

第6章 市場マッピング

第7章 マクロ環境と産業構造

第8章 市場力学

第9章 規制の枠組みとイノベーション

第10章 主要企業の情勢

第11章 価格分析

第12章 ケーススタディ

第13章 主要企業の展望

第14章 戦略的提言

第15章 当社について・免責事項

List of Tables

List of Figures

Table of Contents

1.Research Methodology

2.Project Scope & Definitions

3.Executive Summary

4.Global Topical Drug Delivery Market Outlook, 2017-2031F

5.Global Topical Drug Delivery Market Outlook, By Region, 2017-2031F

6.Market Mapping, 2023

7.Macro Environment and Industry Structure

8.Market Dynamics

9.Regulatory Framework and Innovation

10.Key Players Landscape

11.Pricing Analysis

12.Case Studies

13.Key Players Outlook

14.Strategic Recommendations

15.About Us & Disclaimer

第1章調査手法

第2章プロジェクトの範囲と定義

第3章エグゼクティブサマリー

第4章世界の局所ドラッグデリバリー市場の展望

第5章世界の局所ドラッグデリバリー市場の展望：地域別

第6章市場マッピング

第7章マクロ環境と産業構造

第8章市場力学

第9章規制の枠組みとイノベーション

第10章主要企業の情勢

第11章価格分析

第12章ケーススタディ

第13章主要企業の展望

第14章戦略的提言

第15章当社について・免責事項